The purpose of the study is to compare two types of treatment for atrial fibrillation (AF) that are designed to treat the symptoms of atrial fibrillation. The treatments being compared are: * A single catheter ablation procedure with the investigational EAS, a visually-guided, light-energy catheter * Standard drug therapy (antiarrhythmic drugs) To learn more about the CardioFocus ENABLE investigational clinical study, please contact the study site closest to you. Eligibility Criteria Persons with paroxysmal atrial fibrillation may be eligible for this study. Other study eligibility criteria include: * 18 to 80 years of age * Frequent episodes of AF * Failed at least 1 drug treatment for AF (beta-blockers or standard AADs) * Other criteria
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
64
Single ablation procedure with Endoscopic Ablation System
Medication as prescribed by physician.
Arizona Arrhythmia Consultants
Scottsdale, Arizona, United States
Mercy General Hospital
Sacramento, California, United States
University of California at San Francisco
San Francisco, California, United States
St. John's Health Center
Santa Monica, California, United States
Palm Beach Heart Research Institute
Atlantis, Florida, United States
Florida Hospital
Orlando, Florida, United States
Indiana University, Krannert Institute of Cardiology
Indianapolis, Indiana, United States
Genesis Medical Center
Davenport, Iowa, United States
University of Michigan
Ann Arbor, Michigan, United States
William Beaumont Hospital
Royal Oak, Michigan, United States
...and 8 more locations
Freedom for Symptomatic Episode of Atrial Fibrillation at One Year
Time frame: One Year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.